FDA recall Z-0905-2022

Stanbio Laboratory, LP · Class II · device

Product

Separation Technology Creamatocrit Plus, Catalog Number: 100-146

Reason for recall

The device was being marketed as an IVD without a 510(k). Therefore, performance characteristics of these breast milk analyzers have not been adequately validated. An erroneous result could lead to sub-optimal nutrition supplementation for patients (infants)

Distribution

US Nationwide Distribution CA, TX, OK, SD, IL, NV, MO, FL, WA, KY, WI, PA, NC, GA, MD, MN

Key facts

Status
Terminated
Initiation date
2022-03-16
Report date
2022-04-20
Termination date
2025-01-02
Voluntary/Mandated
Voluntary: Firm initiated
Location
Boerne, TX, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-0905-2022